ViviCells International, Inc.
VCII
$0.00
$0.000.00%
| 09/30/2000 | 06/30/2000 | ||||
|---|---|---|---|---|---|
| Revenue | -65.53% | -15.93% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -65.53% | -15.93% | |||
| Cost of Revenue | -91.06% | -7.03% | |||
| Gross Profit | 50.91% | -41.48% | |||
| SG&A Expenses | -1.73% | 46.89% | |||
| Depreciation & Amortization | 10.42% | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -80.13% | -2.61% | |||
| Operating Income | 141.61% | -71.41% | |||
| Income Before Tax | 108.43% | -80.68% | |||
| Income Tax Expenses | 291.64% | -125.92% | |||
| Earnings from Continuing Operations | -71.39% | -10.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -71.39% | -10.32% | |||
| EBIT | 141.61% | -71.41% | |||
| EBITDA | 137.15% | -70.75% | |||
| EPS Basic | -- | -- | |||
| Normalized Basic EPS | -- | -- | |||
| EPS Diluted | -- | -- | |||
| Normalized Diluted EPS | -- | -- | |||
| Average Basic Shares Outstanding | -- | -- | |||
| Average Diluted Shares Outstanding | -- | -- | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
